Impact of Melatonin on IVF/ICSI Outcomes in Prospective Poor Responders
- Conditions
- In Vitro FertilizationPoor Ovarian Response
- Interventions
- Drug: MelatoninOther: Placebo
- Registration Number
- NCT02993588
- Lead Sponsor
- Assiut University
- Brief Summary
The purpose of this study is to investigate the impact of melatonin administration on in vitro fertilization (IVF/ICSI) outcomes namely the total number and quality of the oocytes and embryos in the prospective poor responders.
- Detailed Description
The prospective poor responders have been associated with lower number and poorer oocyte quality. Melatonin is suggested to have antioxidative effects which may contribute to improving the IVF/ICSI outcomes in this group of patients who expected to have poor outcomes. However, the expected beneficial effects of melatonin have not yet been investigated. The purpose of this study is to investigate the impact of melatonin administration on IVF/ICSI outcomes namely the total number and quality of the oocytes and embryos in the prospective poor responders. A randomized, double-blinded, placebo-controlled study is used to investigate the impact of melatonin on the IVF/ICSI outcomes.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 100
- Prospective poor responder with AMH < 1 ng/ml and AFC < 8 (in both ovaries).
- Severe male factor infertility.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Melatonin Melatonin Melatonin 6 mg tablet once daily. Placebo Placebo Placebo tablet once daily
- Primary Outcome Measures
Name Time Method Total number of retrieved mature oocytes On the day of oocyte retrieval procedure
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Osama Abdalmageed
🇪🇬Assiut, Egypt